Form 8-K - Current report:
SEC Accession No. 0001104659-20-135510
Filing Date
2020-12-15
Accepted
2020-12-15 08:07:52
Documents
15
Period of Report
2020-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2038455d2_8k.htm   iXBRL 8-K 29747
2 EXHIBIT 99.1 tm2038455d2_ex99-1.htm EX-99.1 88535
7 GRAPHIC tm2038455d2_ex99-1img001.jpg GRAPHIC 30926
  Complete submission text file 0001104659-20-135510.txt   394732

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elan-20201215.xsd EX-101.SCH 3898
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20201215_def.xml EX-101.DEF 27027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20201215_lab.xml EX-101.LAB 37941
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20201215_pre.xml EX-101.PRE 25639
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2038455d2_8k_htm.xml XML 5162
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 201388239
SIC: 2834 Pharmaceutical Preparations